BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Voysey M, Kelly DF, Fanshawe TR, Sadarangani M, O'Brien KL, Perera R, Pollard AJ. The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis. JAMA Pediatr 2017;171:637-46. [PMID: 28505244 DOI: 10.1001/jamapediatrics.2017.0638] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Moreno-pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, Merino Moína M, Montesdeoca Melián A, Ruiz-contreras J. Immunisation schedule of the Spanish Association of Paediatrics: 2019 recommendations. Anales de Pediatría (English Edition) 2019;90:56.e1-9. [DOI: 10.1016/j.anpede.2018.11.001] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Parker EPK, Bronowski C, Sindhu KNC, Babji S, Benny B, Carmona-Vicente N, Chasweka N, Chinyama E, Cunliffe NA, Dube Q, Giri S, Grassly NC, Gunasekaran A, Howarth D, Immanuel S, Jere KC, Kampmann B, Lowe J, Mandolo J, Praharaj I, Rani BS, Silas S, Srinivasan VK, Turner M, Venugopal S, Verghese VP, Darby AC, Kang G, Iturriza-Gómara M. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants. Nat Commun 2021;12:7288. [PMID: 34911947 DOI: 10.1038/s41467-021-27074-1] [Reference Citation Analysis]
3 Danchin MH, Bines JE, Watts E, Cowley D, Pavlic D, Lee KJ, Huque H, Kirkwood C, Nirwati H, At thobari J, Dewi Satria C, Soenarto Y, Oktaria V. Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia. Vaccine 2020;38:3235-42. [DOI: 10.1016/j.vaccine.2020.02.087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Rouers EDM, Berbers GAM, van Dongen JAP, Sanders EAM, Bruijning-Verhagen P; PRIEMA study group. Timeliness of immunisations in preterm infants in the Netherlands. Vaccine 2019;37:5862-7. [PMID: 31443994 DOI: 10.1016/j.vaccine.2019.08.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Callaway PC, Farrington LA, Feeney ME. Malaria and Early Life Immunity: Competence in Context. Front Immunol 2021;12:634749. [PMID: 33679787 DOI: 10.3389/fimmu.2021.634749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alameh MG, Weissman D, Pardi N. Messenger RNA-Based Vaccines Against Infectious Diseases. Curr Top Microbiol Immunol 2020. [PMID: 32300916 DOI: 10.1007/82_2020_202] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
7 Wang X, Yang P, Zheng J, Liu P, Wei C, Guo J, Zhang Y, Zhao D. Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants. Sci Rep 2021;11:8021. [PMID: 33850202 DOI: 10.1038/s41598-021-87535-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cinicola B, Conti MG, Terrin G, Sgrulletti M, Elfeky R, Carsetti R, Fernandez Salinas A, Piano Mortari E, Brindisi G, De Curtis M, Zicari AM, Moschese V, Duse M. The Protective Role of Maternal Immunization in Early Life. Front Pediatr 2021;9:638871. [PMID: 33996688 DOI: 10.3389/fped.2021.638871] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Voysey M, Pollard AJ, Sadarangani M, Fanshawe TR. Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates. Vaccine 2017;35:5850-7. [PMID: 28935471 DOI: 10.1016/j.vaccine.2017.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
10 Oguti B, Ali A, Andrews N, Barug D, Anh Dang D, Halperin SA, Thu Hoang HT, Holder B, Kampmann B, Kazi AM, Langley JM, Leuridan E, Madavan N, Maertens K, Maldonado H, Miller E, Munoz-Rivas FM, Omer SB, Pollard AJ, Rice TF, Rots N, Sundaram ME, Wanlapakorn N, Voysey M. The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis. Vaccine 2021:S0264-410X(21)01614-5. [PMID: 34949496 DOI: 10.1016/j.vaccine.2021.12.007] [Reference Citation Analysis]
11 Saso A, Kampmann B, Roetynck S. Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines. Vaccines (Basel) 2021;9:877. [PMID: 34452002 DOI: 10.3390/vaccines9080877] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Perrett KP, Halperin SA, Nolan T, Carmona Martínez A, Martinón-Torres F, García-Sicilia J, Virta M, Vanderkooi OG, Zuccotti GV, Manzoni P, Kostanyan L, Meyer N, Ceregido MA, Cheuvart B, Kuriyakose SO, Stranak Z, Merino Arribas JM, Cilleruelo Ortega MJ, Miranda-Valdivieso M, Arias Novas B, Ramos Amador JT, Omeñaca F, Baca M, Marchisio PG, Mesaros N. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial. Vaccine 2020;38:2105-14. [PMID: 31776027 DOI: 10.1016/j.vaccine.2019.10.104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Thindwa D, Pinsent A, Ojal J, Gallagher KE, French N, Flasche S. Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa. Expert Rev Vaccines 2020;19:1085-92. [PMID: 33269987 DOI: 10.1080/14760584.2020.1843435] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 de Koff EM, van Houten MA, de Heij F, Berbers GAM, Bogaert D, Sanders EAM. Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort. Vaccine 2021:S0264-410X(21)01622-4. [PMID: 34961634 DOI: 10.1016/j.vaccine.2021.12.013] [Reference Citation Analysis]
15 Zimmermann P, Curtis N. Factors That Influence the Immune Response to Vaccination. Clin Microbiol Rev. 2019;32. [PMID: 30867162 DOI: 10.1128/cmr.00084-18] [Cited by in Crossref: 132] [Cited by in F6Publishing: 74] [Article Influence: 44.0] [Reference Citation Analysis]
16 Edwards KM. Protecting Infants From Pertussis Disease. JAMA Pediatr 2018;172:1012-3. [PMID: 30208466 DOI: 10.1001/jamapediatrics.2018.2363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chisenga CC, Bosomprah S, Simuyandi M, Mwila-Kazimbaya K, Chilyabanyama ON, Laban NM, Bialik A, Asato V, Meron-Sudai S, Frankel G, Cohen D, Chilengi R. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study. PLoS One 2021;16:e0252222. [PMID: 34043697 DOI: 10.1371/journal.pone.0252222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Susarla SK, Gupta M, Mantan M, Dhongade R, Bhave S, Das RK, Ray RK, Ramesh Babu T, Ravi MD, Krishnamurthy B, James S, Sandhya G, Satish M, Sahoo DP. Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study. Vaccine 2019;37:5452-9. [PMID: 31331773 DOI: 10.1016/j.vaccine.2019.06.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Morcrette H, Bokori-Brown M, Ong S, Bennett L, Wren BW, Lewis N, Titball RW. Clostridium perfringens epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein. NPJ Vaccines 2019;4:32. [PMID: 31372245 DOI: 10.1038/s41541-019-0128-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yougbare I, McTague A, He L, Choy CH, Su J, Gajewska B, Azizi A. Anti-FIM and Anti-FHA Antibodies Inhibit Bordetella pertussis Growth and Reduce Epithelial Cell Inflammation Through Bacterial Aggregation. Front Immunol 2020;11:605273. [PMID: 33384692 DOI: 10.3389/fimmu.2020.605273] [Reference Citation Analysis]
21 Yadav R, Zhai L, Tumban E. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today? Viruses 2019;12:E18. [PMID: 31877975 DOI: 10.3390/v12010018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
22 Sáez-Llorens X, Thierry-Carstensen B, Stoey LS, Sørensen C, Wachmann H, Bandyopadhyay AS, Nielsen PI, Kusk MV. Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months. Vaccine 2020;38:3780-9. [PMID: 32273184 DOI: 10.1016/j.vaccine.2020.02.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Dobaño C, Ubillos I, Jairoce C, Gyan B, Vidal M, Jiménez A, Santano R, Dosoo D, Nhabomba AJ, Ayestaran A, Aguilar R, Williams NA, Díez-Padrisa N, Lanar D, Chauhan V, Chitnis C, Dutta S, Gaur D, Angov E, Asante KP, Owusu-Agyei S, Valim C, Gamain B, Coppel RL, Cavanagh D, Beeson JG, Campo JJ, Moncunill G. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study. BMC Med 2019;17:157. [PMID: 31409398 DOI: 10.1186/s12916-019-1378-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
24 Song JR, Fu YW, Li P, Du T, Du XJ, Wang S. Protective Effect of Recombinant Proteins of Cronobacter Sakazakii During Pregnancy on the Offspring. Front Cell Infect Microbiol 2020;10:15. [PMID: 32076598 DOI: 10.3389/fcimb.2020.00015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gómara M, Prendergast AJ, Grassly NC. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol 2018;13:97-118. [PMID: 29218997 DOI: 10.2217/fmb-2017-0128] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
26 Kandeil W, Savic M, Ceregido MA, Guignard A, Kuznetsova A, Mukherjee P. Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect? Expert Rev Vaccines 2020;19:341-52. [PMID: 32237928 DOI: 10.1080/14760584.2020.1749597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Zimmermann P, Jones CE. Factors That Influence Infant Immunity and Vaccine Responses. Pediatr Infect Dis J 2021;40:S40-6. [PMID: 34042910 DOI: 10.1097/INF.0000000000002773] [Reference Citation Analysis]
28 Becker-Dreps S, Butler AM, McGrath LJ, Boggess KA, Weber DJ, Li D, Hudgens MG, Layton JB. Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S. Am J Prev Med 2018;55:159-66. [PMID: 29910115 DOI: 10.1016/j.amepre.2018.04.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
29 Marlow R, Kuriyakose S, Mesaros N, Han HH, Tomlinson R, Faust SN, Snape MD, Pollard AJ, Finn A. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Vaccine 2018;36:2300-6. [DOI: 10.1016/j.vaccine.2018.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
30 Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial. Lancet Infect Dis 2019;19:392-401. [PMID: 30938299 DOI: 10.1016/S1473-3099(18)30717-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
31 Moreno-Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, Merino Moína M, Montesdeoca Melián A, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). [Immunisation schedule of the Spanish Association of Paediatrics: 2019 recommendations]. An Pediatr (Engl Ed) 2019;90:56.e1-9. [PMID: 30609975 DOI: 10.1016/j.anpedi.2018.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
32 Moreno-Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, Merino Moína M, Montesdeoca Melián A, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). [Immunisation schedule of the Spanish Association of Paediatrics: 2018 recommendations]. An Pediatr (Engl Ed) 2018;88:53.e1-9. [PMID: 29301718 DOI: 10.1016/j.anpedi.2017.10.001] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wood N, Nolan T, Marshall H, Richmond P, Gibbs E, Perrett K, McIntyre P. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. JAMA Pediatr 2018;172:1045-52. [PMID: 30208475 DOI: 10.1001/jamapediatrics.2018.2349] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
34 [DOI: 10.1101/2020.11.02.20224576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Kawahara T, Fukuda M, Oba K, Sakamoto J, Buyse M. Meta-analysis of randomized clinical trials in the era of individual patient data sharing. Int J Clin Oncol 2018;23:403-9. [PMID: 29330642 DOI: 10.1007/s10147-018-1237-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Willis E, Pardi N, Parkhouse K, Mui BL, Tam YK, Weissman D, Hensley SE. Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice. Sci Transl Med 2020;12:eaav5701. [PMID: 31915303 DOI: 10.1126/scitranslmed.aav5701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
37 Okala SG, Darboe MK, Sosseh F, Sonko B, Faye-Joof T, Prentice AM, Moore SE. Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia. PLoS Med 2019;16:e1002854. [PMID: 31386660 DOI: 10.1371/journal.pmed.1002854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
38 Kollmann TR, Marchant A, Way SS. Vaccination strategies to enhance immunity in neonates. Science 2020;368:612-5. [PMID: 32381718 DOI: 10.1126/science.aaz9447] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
39 O'Connor D, Png E, Khor CC, Snape MD, Hill AVS, van der Klis F, Hoggart C, Levin M, Hibberd ML, Pollard AJ. Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization. Cell Rep 2019;27:3241-3253.e4. [PMID: 31189108 DOI: 10.1016/j.celrep.2019.05.053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
40 Langel SN, Otero CE, Martinez DR, Permar SR. Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection. PLoS Pathog 2020;16:e1008303. [PMID: 32214394 DOI: 10.1371/journal.ppat.1008303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Kachikis A, Eckert LO, Englund J. Who's the Target: Mother or Baby? Viral Immunol 2018;31:184-94. [PMID: 29474132 DOI: 10.1089/vim.2017.0135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Kidzeru E, Gasper MA, Shao D, Edlefsen PT, Lejarcegui N, Havyarimana E, Urdahl K, Gantt S, Horton H, Jaspan H, Gervassi A. Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infants. J Leukoc Biol 2021. [PMID: 33477200 DOI: 10.1002/JLB.5A0420-281R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rouers EDM, Bruijning-Verhagen PCJ, van Gageldonk PGM, van Dongen JAP, Sanders EAM, Berbers GAM. Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants. JAMA 2020;324:1068-77. [PMID: 32930758 DOI: 10.1001/jama.2020.12316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Gaensbauer JT, Gast C, Bandyopadhyay AS, O'Ryan M, Saez-Llorens X, Rivera L, Lopez-Medina E, Melgar M, Weldon WC, Oberste MS, Rüttimann R, Clemens R, Asturias EJ. Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame. Clin Infect Dis 2018;67:S57-65. [PMID: 30376095 DOI: 10.1093/cid/ciy649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
45 Velasquez DE, Parashar U, Jiang B. Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors. Expert Rev Vaccines 2018;17:145-61. [PMID: 29252042 DOI: 10.1080/14760584.2018.1418665] [Cited by in Crossref: 14] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
46 Abu-Raya B, Maertens K, Munoz FM, Zimmermann P, Curtis N, Halperin SA, Rots N, Barug D, Holder B, Rice TF, Kampmann B, Leuridan E, Sadarangani M. Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis. Vaccine 2021;39:6545-52. [PMID: 34598822 DOI: 10.1016/j.vaccine.2021.09.022] [Reference Citation Analysis]
47 Jia S, Tang R, Li G, Hu Y, Liang Q. The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines. BMC Infect Dis 2020;20:641. [PMID: 32867698 DOI: 10.1186/s12879-020-05348-1] [Reference Citation Analysis]
48 Heininger U. [Pertussis (whooping cough)]. Monatsschr Kinderheilkd 2020;:1-12. [PMID: 32836397 DOI: 10.1007/s00112-020-00941-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Anthony N, Pellen C, Ohmann C, Moher D, Naudet F. Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals. BMC Med Res Methodol 2021;21:119. [PMID: 34092224 DOI: 10.1186/s12874-021-01311-z] [Reference Citation Analysis]
50 Middleton BF, Jones MA, Waddington CS, Danchin M, McCallum C, Gallagher S, Leach AJ, Andrews R, Kirkwood C, Cunliffe N, Carapetis J, Marsh JA, Snelling T. The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis. BMJ Open 2019;9:e032549. [PMID: 31727664 DOI: 10.1136/bmjopen-2019-032549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Smith C, Huo Y, Patel K, Fetters K, Hegemann S, Burchett S, Van Dyke R, Weinberg A; Pediatric HIV/AIDS Cohort Study (PHACS) and IMPAACT P1025 study team. Immunologic and Virologic Factors Associated with Hospitalization in HIV-Exposed, Uninfected Infants in the United States. Clin Infect Dis 2021:ciab272. [PMID: 34157096 DOI: 10.1093/cid/ciab272] [Reference Citation Analysis]
52 Zimmermann P, Perrett KP, Messina NL, Donath S, Ritz N, van der Klis FRM, Curtis N. The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses. EClinicalMedicine 2019;13:21-30. [PMID: 31517260 DOI: 10.1016/j.eclinm.2019.06.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
53 Abu Raya B, Sadarangani M. Meningococcal vaccination in pregnancy. Hum Vaccin Immunother 2018;14:1188-96. [PMID: 29485347 DOI: 10.1080/21645515.2018.1445447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 2021;21:83-100. [PMID: 33353987 DOI: 10.1038/s41577-020-00479-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 64] [Article Influence: 21.5] [Reference Citation Analysis]
55 Abreu TC, Boshuizen H, Mollema L, Berbers GAM, Korthals Altes H. Association between season of vaccination and antibody levels against infectious diseases. Epidemiol Infect 2020;148:e276. [PMID: 33148351 DOI: 10.1017/S0950268820002691] [Reference Citation Analysis]
56 Bravo LC, Carlos JC, Gatchalian SR, Montellano MEB, Tabora CFCB, Thierry-Carstensen B, Tingskov PN, Sørensen C, Wachmann H, Bandyopadhyay AS, Nielsen PI, Kusk MV. Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age. Vaccine 2020;38:530-8. [PMID: 31703934 DOI: 10.1016/j.vaccine.2019.10.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Zimmermann P, Perrett KP, Ritz N, Flanagan KL, Robins-Browne R, van der Klis FRM, Curtis N; MIS BAIR group. Biological sex influences antibody responses to routine vaccinations in the first year of life. Acta Paediatr 2020;109:147-57. [PMID: 31610635 DOI: 10.1111/apa.14932] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Callahan EA, Chatila T, Deckelbaum RJ, Field CJ, Greer FR, Hernell O, Järvinen KM, Kleinman RE, Milner J, Neu J, Smolen KK, Wallingford JC. Assessing the safety of bioactive ingredients in infant formula that affect the immune system: Recommendations from an expert panel. Am J Clin Nutr 2021:nqab346. [PMID: 34634105 DOI: 10.1093/ajcn/nqab346] [Reference Citation Analysis]
59 Ibrahim R, Ali SA, Kazi AM, Rizvi A, Guterman LB, Bednarczyk RA, Kim E, Park S, Paulos S, Jeyachandran A, Patel D, Gorantla Y, Wong E, Rajam G, Schiffer J, Omer SB. Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting. Vaccine 2018;36:7048-53. [PMID: 30297122 DOI: 10.1016/j.vaccine.2018.09.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]